US widens Ebola ban to green-card holders

The PABS deadlock has a structural root cause that predates the current outbreak: roughly 100 LMIC member states demand that rapid pathogen-data sharing be contractually linked to guaranteed access to vaccines and treatments derived from those sequences, while high-income bloc states, protecting pharmaceutical IP arrangements and open-sequence-data norms, have refused to make vaccine access legally binding.

DRC is currently demonstrating the LMIC position in real time: it shared Bundibugyo sequence data under existing surveillance norms, vaccine investment arrived via CEPI and GAVI, and DRC nationals simultaneously face a US entry ban.

The green-card expansion by HHS has a domestic legal root cause separate from the epidemiology: the 18 May order's original exclusion of lawful permanent residents was challenged on due-process grounds under the Fifth Amendment, and the expansion to include them likely reflects administration legal advice that the original order's carve-out was inconsistent with the public-health emergency rationale.

The green-card expansion represents an escalation from the 18 May entry ban: extending to lawful permanent residents means the restriction now covers a class of people with established legal ties to the US, raising constitutional challenge risk and creating a stronger diplomatic friction point.

The ban's ~17 June expiry creates a near-term decision point: extend, allow to lapse, or replace with a monitoring framework. Kinshasa's active negotiation for early lifting suggests a deal on enhanced screening in lieu of the ban is the most probable outcome, but the outcome depends on outbreak trajectory over the next eight days.